GDF15 As a Differential Marker for Spondyloarthropathy

In vitro methods for differential diagnosis of spondyloarthropathy are disclosed which involve determining the levels of GDF15 in biological samples.

Attached files:


Patents:
WO 2,010,094,709   [MORE INFO]

Inventor(s): LAMBRECHT STIJN [BE]; DEFORCE DIETER [BE]; ELEWAUT DIRK [BE]; VERBRUGGEN AUGUST [BE]

Type of Offer: Sale



« More Diagnostic Patents

---